News & Events

Primary tabs

LaBaer featured panelist at BioPolicy Summit on research reproducibility

February 2, 2016

ASU Biodesign Institute interim executive director Dr. Joshua LaBaer, MD, PhD, will be headed to the nation's capital next week to participate in an esteemed panel of top bioscience leaders as part of the 2016 Global BioPolicy Summit.  On Tuesday, February 9, at 12:00 noon EST, Global Biological Standards Institute (GBSI) will host its 2016 BioPolicy Summit at the Newseum in Washington, DC. The 2016 Summit—Research Reproducibility: Innovative Solutions to Drive Quality welcomes LaBaer...

ASU names LaBaer interim executive director of the Biodesign Institute

January 13, 2016

Dr. Joshua L. LaBaer, a leading researcher in cancer and personalized medicine, has been named interim executive director for the Biodesign Institute at Arizona State University.   “LaBaer’s leadership will ensure that we continue our progress toward establishing the Biodesign Institute as a world-class research institute focused on solving key societal challenges in health, sustainability and national security,” said Sethuraman Panchanathan, senior vice president of ASU’s Office...

New ASU worldwide resource for exploring genes’ hidden messages

December 11, 2015

After a decade-long $3 billion international effort, scientists heralded the 2001 completion of the human genome as a moon landing achievement for biology and the key to finally solving intractable diseases like cancer. But it turns out this was only the end of the beginning, with a much greater complexity to life revealed by the roughly 20,000 genes found within the human genome. For one, most diseases are incredibly complex, with very few caused by a single gene mutation. Rather, the more...

ASU, Mayo Clinic collaborate to advance medicine through joint research

December 1, 2015

2016 seed-grant recipients announced Arizona State University, in partnership with Mayo Clinic in Arizona, has announced the recipients of the 2016 ASU-Mayo Seed Grant Program. The program funds critical joint research projects in the health field led by scientists from both ASU and Mayo Clinic. The awardees this year are making innovative strides in the treatment of cancer, Alzheimer’s, Parkinson’s, heart failure and infectious diseases, as well as advancing nanobody technology and...

Biodesign’s Anderson named Health Care Hero

August 25, 2015

The Phoenix Business Journal has named ASU Biodesign Institute and Mayo Clinic cancer researcher Karen Anderson, M.D., Ph.D., a Health Care Hero and presented her with its annual top doctor honor, the 2015 Physician Award. Anderson’s front-line work in oncology is leading a momentous shift to better match treatments based on each patient’s unique genetic profile, called precision medicine. At ASU’s Biodesign Institute, Anderson and her colleagues are developing new ways to diagnose...

What are you going to do about it?

April 21, 2015

“You folks are doing fabulous, world-changing work here.” -Jude LaCava   Guest blogger and local Fox10 sportscaster Jude LaCava shares with us his personal story of how he became involved in supporting game-changing Biodesign cancer research.    by Jude LaCava I live in a world of games as a sports reporter.  Covering athletic contests is like covering the toy department of life. But my passion is what really matters in life and that is life...

Surveying telltale signs of ovarian cancer

March 12, 2015

This year, ovarian cancer will claim over 125,000 lives worldwide. The deadly disease remains the fifth leading cause of cancer-related mortality in U.S. women, killing about 15,000 per year.  While diagnostic screening has long been a watchword, efforts to identify the disease in its early stages often fail. By the time ovarian cancer is detected, it has typically progressed to an advanced phase, where the 5-year survival rate falls below 30 percent.  Josh LaBaer, MD, PhD., and...

Lecture explores life by other means

February 23, 2015

The lecture, entitled "Where Biochemical Causality and Emergence Meet," was part of a special session: "Searching for Alternative Chemistries of Life on Earth and Throughout the Universe."   The interlinked lectures posed fundamental questions regarding the nature of life and plausible alternatives to what biologists refer to as “the central dogma,” which describes the flow of genetic information from DNA to RNA to proteins.   The central dogma neatly describes a process...

ASU Biodesign Institute hosts national proteomics conference

February 19, 2015

Arizona State University will host leaders of a premiere national research organization at the 11th Annual U.S. Human Proteome Organzation (HUPO) national conference, March 15 through Wednesday, March 18, 2015. Billed as “not your grandparents proteomics meeting,” this year’s theme of “Next Generation Proteomics” will provide opportunities to experience presentations from top scientists, both up-and-coming and established, on cutting-edge topics.      Among the...

Ebola: new studies model a deadly epidemic

February 5, 2015

On Dec. 26, 2013, a two-year-old boy living in the Guinean village of Meliandou, Guéckédou Prefecture was stricken with a rare disease, caused by the filament-shaped Ebola virus. The child is believed to be the first case in what soon became a flood-tide of contagion, ravaging the West African countries of Guinea, Sierra Leone and Liberia, infecting over 21,000 cases as of Jan. 21, according to the World Health Organization, with nearly 9000 confirmed deaths—the actual toll likely...